As part of our ongoing commitment to strengthening our expertise, we are proud to inform that Ulf Andersson has joined our Board of Directors, effective June 2024.

Ulf Andersson joins us with an impressive background in leadership roles at globally recognized companies. He holds a master’s degree in engineering physics from Chalmers University of Technology in Sweden and brings extensive experience in product development, with more than 10 years in the medical technology sector. As the former CTO of Getinge, within the Business Area for Acute Care Therapies, Ulf managed technology development across a broad range of products, including Intensive Care Ventilators, Anesthesia Machines and Extra Corporeal Life Support products. His most recent position was Vice President of Research and Platforms at Getinge, where he engaged in technology and process alignment across the group.

“I am excited to join VentriLabs and look forward to contributing to the company’s continued innovation and helping drive the development of cutting-edge technologies”, says Ulf.

With Ulf’s vast experience in both engineering and medical technologies, VentriLabs stands poised to strengthen its product development pipeline. His strategic insights and leadership in scaling innovation will be instrumental as we continue to enhance our offerings in the medical technology space. Ulf’s proven ability to lead large-scale projects and foster cross-functional collaboration will be a valuable asset to the team.

“We are immensely proud that Ulf has accepted to join our team, and we are confident that his expertise will significantly accelerate our progress”, says Einar Pontén, Chairman of the Board.